Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.

ABSTRACT:

Background

Previous studies have demonstrated a substantial economic impact of irritable bowel syndrome (IBS).

Aims

To provide contemporaneous estimates of direct healthcare costs of IBS in the United Kingdom.

Methods

We collected demographic, gastrointestinal and psychological symptoms, quality of life and healthcare usage data from adults with Rome IV or Rome III IBS in the United Kingdom. We calculated the mean annual direct healthcare costs of IBS per person and used contemporaneous IBS prevalence data, together with census data, to estimate annual direct costs of IBS. We also examined predictors of higher costs.

Results

The mean annual direct cost of IBS per person among 752 individuals with Rome IV IBS was £556.65 (SD £1023.92) and £474.16 (SD £897.86) fo

SUBMITTER: Goodoory VC 

PROVIDER: S-EPMC9325446 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature